2026 Capital Expenditure Plan
Company: Core Scientific
The claim, verbatim
2026 capital expenditure plan of approximately $2 billion, assuming no new customer contract
Source (primary)
First Quarter Fiscal Year 2026 Earnings Presentation (IR page (investors.corescientific.com), ir_presentation)
View cached copy (2026-09-26)Live source ↗Archive.org ↗
Quote: “2026 CapEx plan of ~$2B, as of May 6, 2026, assumes no new customer contract”
How we checked this
Checked on October 12, 2026. The cited source supports every part of this claim.
A footnote states the 2026 CapEx plan of ~$2B, as of May 6, 2026, assumes no new customer contract.
Confirmed in the source:
- Core Scientific's 2026 capex plan is approximately $2 billion
- The plan assumes no new customer contract
What we did: Read our cached copy of IR page (investors.corescientific.com) (https://d1io3yog0oux5.cloudfront.net/_fda3a1f2f1890adaa7ac6c4d9d310971/corescientific/db/1066/11271/pdf/Q1+FY26+earnings+deck.pdf) in full (14,811 characters, retrieved September 26, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms First Quarter Fiscal Year 2026 Earnings Presentation
Quote: “2026 CapEx plan of ~$2B, as of May 6, 2026, assumes no new customer contract”